Market News

Latest financial news from across the markets

Daily Market Overview

U.S. stock futures are holding steady amid a backdrop of heightened anxiety over AI disruption and renewed tariff threats from former President Trump, following a recent Supreme Court ruling that overturned many of his tariffs. Major indexes experienced a sell-off, with tech stocks particularly affected, as fears about AI's impact on the market continue to loom large. In corporate news, IBM's shares plummeted 13% due to concerns over competition from AI, while Eli Lilly gained ground following a successful trial against rival Novo Nordisk in the obesity treatment sector. Additionally, FedEx is seeking a refund for tariffs imposed during the Trump administration, highlighting ongoing trade tensions.

Latest Market Updates

Tuesday's stock stories: What’s likely to move the market in the next session

Tuesday's stock stories: What’s likely to move the market in the next session

less than a minute ago

Stock futures are little changed after major indexes sell off on anxiety over AI disruption, tariffs

Stock futures are little changed after major indexes sell off on anxiety over AI disruption, tariffs

less than a minute ago

FedEx sues for refund of Trump tariffs, days after Supreme Court ruling

FedEx sues for refund of Trump tariffs, days after Supreme Court ruling

less than a minute ago

What Supreme Court tariff ruling means for global trade and the U.S. economy

What Supreme Court tariff ruling means for global trade and the U.S. economy

less than a minute ago

AI fears and tariff confusion spook U.S. markets

AI fears and tariff confusion spook U.S. markets

16 minutes ago

Asia markets trade mixed after Trump revives tariff threat and AI fears hit tech

Asia markets trade mixed after Trump revives tariff threat and AI fears hit tech

25 minutes ago

Hims & Hers’ expansion plans — as well as its Super Bowl ad — have investors worried about profits

The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.

31 minutes ago